Keeping the Pathway Focus on Treatment Instead of Cost Will Ensure the Best Care

Meir Rinde
Published: Sunday, Jun 11, 2017
Gordon Kuntz

Gordon Kuntz

Clinical pathways were originally created to standardize cancer care and ensure patients receive the best evidence-based treatment for their disease. A divide has developed, however, between pathways that primarily serve physicians and those that cater to payers that are trying to rein in costs. Among those on the side of physicians and practices is Via Oncology, a Pittsburgh-based pathway development company whose pathways emphasize drug efficacy and toxicity rather than price, said Gordon Kuntz, Via’s senior director of strategy.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication